FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000508004: Great Britain English language reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001112010 Great Britain English language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001113017 GB English en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001114011 Great Britain English language reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

1327206 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
GB English Is a English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept) true Inferred relationship Some
Members acceptabilityId
17-ketosteroid (substance) Preferred (foundation metadata concept)
17-ketosteroid in urine specimen above reference range Acceptable (foundation metadata concept)
17-ketosteroid in urine specimen above reference range (finding) Preferred (foundation metadata concept)
17-ketosteroids level above reference range Preferred (foundation metadata concept)
17-ketosteroids level above reference range (finding) Preferred (foundation metadata concept)
17-ketosteroids level below reference range Preferred (foundation metadata concept)
17-ketosteroids level below reference range (finding) Preferred (foundation metadata concept)
17-ketosteroids within reference range Preferred (foundation metadata concept)
17-ketosteroids within reference range (finding) Preferred (foundation metadata concept)
17-oxosteroid Acceptable (foundation metadata concept)
17-oxosteroids Acceptable (foundation metadata concept)
17.7 Preferred (foundation metadata concept)
17.7 (qualifier value) Preferred (foundation metadata concept)
17.8 Preferred (foundation metadata concept)
17.8 (qualifier value) Preferred (foundation metadata concept)
17/22 Preferred (foundation metadata concept)
17/25 Preferred (foundation metadata concept)
170 Preferred (foundation metadata concept)
170 (qualifier value) Preferred (foundation metadata concept)
170-Hf Acceptable (foundation metadata concept)
17000 Preferred (foundation metadata concept)
17000 (qualifier value) Preferred (foundation metadata concept)
171-Hf Acceptable (foundation metadata concept)
172 Preferred (foundation metadata concept)
172 (qualifier value) Preferred (foundation metadata concept)
172-Hf Acceptable (foundation metadata concept)
172.5 Preferred (foundation metadata concept)
172.5 (qualifier value) Preferred (foundation metadata concept)
1720 Preferred (foundation metadata concept)
1720 (qualifier value) Preferred (foundation metadata concept)
173-Hf Acceptable (foundation metadata concept)
173-Ta Acceptable (foundation metadata concept)
174 Preferred (foundation metadata concept)
174 (qualifier value) Preferred (foundation metadata concept)
174-Hf Acceptable (foundation metadata concept)
174-Ta Acceptable (foundation metadata concept)
175 Preferred (foundation metadata concept)
175 (qualifier value) Preferred (foundation metadata concept)
175-Hf Acceptable (foundation metadata concept)
175-Ta Acceptable (foundation metadata concept)
175-Yb Acceptable (foundation metadata concept)
175.439 Preferred (foundation metadata concept)
175.439 (qualifier value) Preferred (foundation metadata concept)
1750 Preferred (foundation metadata concept)
1750 (qualifier value) Preferred (foundation metadata concept)
17500 Preferred (foundation metadata concept)
17500 (qualifier value) Preferred (foundation metadata concept)
176-Ta Acceptable (foundation metadata concept)
176-W Acceptable (foundation metadata concept)
177-Lu Acceptable (foundation metadata concept)
177-Ta Acceptable (foundation metadata concept)
177-W Acceptable (foundation metadata concept)
177-Yb Acceptable (foundation metadata concept)
17700 Preferred (foundation metadata concept)
17700 (qualifier value) Preferred (foundation metadata concept)
177LU-DOTA-HH1 Acceptable (foundation metadata concept)
178-Ta Acceptable (foundation metadata concept)
178-W Acceptable (foundation metadata concept)
179 Preferred (foundation metadata concept)
179 (qualifier value) Preferred (foundation metadata concept)
179-Ta Acceptable (foundation metadata concept)
17B-HSD deficiency Acceptable (foundation metadata concept)
17G Preferred (foundation metadata concept)
17G (qualifier value) Preferred (foundation metadata concept)
17KGS - 17-ketogenic steroid Acceptable (foundation metadata concept)
17alpha-hydroxyprogesterone aldolase Preferred (foundation metadata concept)
17alpha-hydroxyprogesterone aldolase (substance) Preferred (foundation metadata concept)
17beta,20alpha-hydroxy-steroid dehydrogenase Acceptable (foundation metadata concept)
17beta-Hydroxyandrost-4-en-3-one decanoate Acceptable (foundation metadata concept)
17p partial trisomy syndrome Preferred (foundation metadata concept)
17p partial trisomy syndrome (disorder) Preferred (foundation metadata concept)
17p11.2 microduplication syndrome Preferred (foundation metadata concept)
17p11.2 microduplication syndrome (disorder) Preferred (foundation metadata concept)
17p11.2 microduplication syndrome is a rare chromosomal anomaly syndrome, resulting from the partial duplication of the short arm of chromosome 17, typically characterised by hypotonia, poor feeding, failure to thrive, developmental delay (particularly cognitive and language deficits), mild-moderate intellectual deficit, and neuropsychiatric disorders (behavioural problems, anxiety, attention deficit hyperactivity disorder, autistic spectrum disorder, bipolar disorder). Structural cardiovascular anomalies (dilated aortic root, bicommissural aortic valve, atrial/ventricular and septal defects) and sleep disturbance (obstructive and central sleep apnoea) are also frequently associated. Preferred (foundation metadata concept)
17p11.2p12 microduplication syndrome Acceptable (foundation metadata concept)
17p13.3 microduplication syndrome Preferred (foundation metadata concept)
17p13.3 microduplication syndrome (disorder) Preferred (foundation metadata concept)
17p13.3 microduplication syndrome is characterised by variable psychomotor delay and dysmorphic features. Preferred (foundation metadata concept)
17q partial trisomy syndrome Preferred (foundation metadata concept)
17q partial trisomy syndrome (disorder) Preferred (foundation metadata concept)
17q11 deletion syndrome Preferred (foundation metadata concept)
17q11 deletion syndrome (disorder) Preferred (foundation metadata concept)
17q11 microdeletion syndrome is a rare severe form of neurofibromatosis type 1 characterised by mild facial dysmorphism, developmental delay, intellectual disability, increased risk of malignancies, and a large number of neurofibromas. Preferred (foundation metadata concept)
17q11.2 microduplication syndrome Preferred (foundation metadata concept)
17q11.2 microduplication syndrome (disorder) Preferred (foundation metadata concept)
17q11.2 microduplication syndrome is characterised by dysmorphic features and intellectual deficit. Preferred (foundation metadata concept)
17q12 duplication syndrome Acceptable (foundation metadata concept)
17q12 microdeletion syndrome Preferred (foundation metadata concept)
17q12 microdeletion syndrome (disorder) Preferred (foundation metadata concept)
17q12 microdeletion syndrome is a rare chromosomal anomaly syndrome resulting from the partial deletion of the long arm of chromosome 17 characterised by renal cystic disease, maturity onset diabetes of the young type 5, and neurodevelopmental disorders, such as cognitive impairment, developmental delay (particularly of speech), autistic traits and autism spectrum disorder. Mullerian aplasia in females, macrocephaly, mild facial dysmorphism (high forehead, deep set eyes and chubby cheeks) and transient hypercalcaemia have also been reported. Preferred (foundation metadata concept)
17q12 microduplication syndrome Preferred (foundation metadata concept)
17q12 microduplication syndrome (disorder) Preferred (foundation metadata concept)
17q12 microduplication syndrome is a rare chromosomal anomaly with variable phenotypic expression and reduced penetrance associated with developmental delay, mild to severe intellectual disability, speech delay, seizures, microcephaly, behavioural abnormalities, autism spectrum disorder, eye or vision defects (such as strabismus, astigmatism, amblyopia, cataract, coloboma, and microphthalmia), non-specific dysmorphic features, hypotonia, cardiac and renal anomalies, schizophrenia. Preferred (foundation metadata concept)
17q21.31 microduplication syndrome Preferred (foundation metadata concept)
17q21.31 microduplication syndrome (disorder) Preferred (foundation metadata concept)
17q23.1-q23.2 duplication syndrome Preferred (foundation metadata concept)
17q23.1-q23.2 duplication syndrome (disorder) Preferred (foundation metadata concept)
17q23.1q23.2 microdeletion syndrome Preferred (foundation metadata concept)
17q23.1q23.2 microdeletion syndrome (disorder) Preferred (foundation metadata concept)
17q23.1q23.2 microdeletion syndrome is a recently described syndrome characterised by developmental delay, microcephaly, short stature, heart defects and limb abnormalities. Preferred (foundation metadata concept)
17q24-qter duplication syndrome Preferred (foundation metadata concept)

Start Previous Page 75 of 13273 Next End

Reference Sets

Reference set descriptor

Back to Start